Latest news
Porton Advanced Secures China Commercial Manufacturing Licence for Cell and Gene Therapy CDMO Services - BioPharma APACBioPharma APAC · Sat, 08 Aug 2026 06:01:51 GMTLineage Cell Therapeutics (LCTX) Stock Faces Cash Burn Despite Paper Profit - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:21:42 GMTLineage Cell Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:30:00 GMTBlue Cell Therapeutics shuts in vivo unit ahead of clinical trial: Staff laid off - medwatch.commedwatch.com · Fri, 07 Aug 2026 12:06:35 GMTCD19 Therapeutics Market - Future Market InsightsFuture Market Insights · Fri, 07 Aug 2026 10:15:41 GMTLineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:12:00 GMTMiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:10 GMTLineage Cell Therapeutics (NYSEARCA:LCTX) Slips on Q2 Revenue Miss, but EPS In Line and Pipeline Advances - ChartMillChartMill · Thu, 06 Aug 2026 21:46:37 GMT